The growing unease around the safety of testosterone supplements has been highlighted by a US Food and Drug Administration announcement that the products must now carry a warning label on the general risk of blood clots in the veins. The warning is not related to the FDA’s ongoing investigation into the risk of stroke, heart attack and death in those taking testosterone products.
[link url=http://www.medicinenet.com/script/main/art.asp?articlekey=179132]Full Medicinenet report[/link]
MedicalBrief is Africa’s authoritative weekly digest of medical matters, both on the continent and around the world. It brings you a succinct summary of the latest developments, both in news and research, with links to the original material. Contact us: info@medicalbrief.co.za
| Cookie | Duration | Description |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |
